healthcare reform

Patients who've learned their genetic risk of disease worry about healthcare law changes in the US, Kaiser Health News reports.

The amount of activity last year on the regulatory, reimbursement, legislative, educational, and intellectual property fronts is a sign that the wheels are slowly shifting toward creating a framework that will someday support and deliver genomically guided medicine, even though plenty of barriers and challenges need to be overcome on the path to that goal.

The healthcare reform bill includes a section on comparative effectiveness research that creates the Patient-Centered Outcomes Research Institute. Seen as a victory for personalized medicine, the institute will study the utility of medical products in "various subpopulations," including groups differentiated by genetic and molecular subtypes.

The healthcare reform bill, expected to be signed into law by President Obama on March 23, includes a section on comparative effectiveness research that creates the Patient-Centered Outcomes Research Institute.

In a hearing overshadowed by a looming healthcare debate, the secretary-designate cited genomics research first in her list of important HHS duties.

Industry stakeholders and patient advocates are urging the government to ensure that any resulting comparative effectiveness program not focus solely on reducing cost but on using pharmacogenomics to improve patient outcomes.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.